FLT3 and cancer: The most significantly enriched pathway in this study was transcriptional misregulation in cancer (hsa05202) (p < 0.01, FDR = 0.001), which was closely related to the most enriched GO MF category, DNA-binding transcription activator activity related to RNA polymerase II-specific (GO:0001228) (p < 0.01, FDR = 0.4), with four overlapping genes that includes hub genes such as FLT3 and CEBPA, as listed in Tables S4 and S6, Supplementary File S2.